Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

ClinicalTrials.gov ID: NCT03470545

Public ClinicalTrials.gov record NCT03470545. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, international, double-blind study of the administration of mavacamten in participants with symptomatic obstructive HCM (oHCM). Approximately 220 participants will be randomized to receive placebo or mavacamten.

Study identification

NCT ID
NCT03470545
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MyoKardia, Inc.
Industry
Enrollment
251 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 29, 2018 (Actual)
Primary completion
Mar 14, 2020 (Actual)
Completion
May 6, 2020 (Actual)
Last update posted
Oct 4, 2021

2018 – 2020

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Mayo Clinic Arizona Scottsdale Arizona 85259 —
Cedars-Sinai Medical Center (Smidt Heart Institute) Los Angeles California 90048 —
UCSF School of Medicine San Francisco California 94143 —
Stanford University Stanford California 94305 —
Yale New Haven Hospital New Haven Connecticut 16511 —
Mayo Clinic Jacksonville - PPDS Jacksonville Florida 32224 —
Northwestern University Chicago Illinois 60611 —
University Of Iowa Hospitals And Clinics Iowa City Iowa 52242 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Spectrum Health Grand Rapids Michigan 49512 —
Washington University School of Medicine St Louis Missouri 63110 —
NYU Langone Medical Center New York New York 10017 —
Columbia University Medical Center New York New York 10032 —
Carolinas Medical Center Charlotte North Carolina 28203 —
Duke Cardiology at Southpoint Durham North Carolina 27710 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Oregon Health & Science University Portland Oregon 97239 —
St. Luke's Cardiology Associates Bethlehem Pennsylvania 18018 —
University of Pennsylvania (Penn Heart and Vascular Center) Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Presbyterian Pittsburgh Pennsylvania 15213 —
Methodist University Hospital Memphis Tennessee 38163 —
University of Texas Southwestern Medical Center Dallas Texas 75235 —
Houston Methodist Hospital Houston Texas 77030 —
University of Texas Houston Medical School Houston Texas 77030 —
Intermountain Medical Center Salt Lake City Utah 84107 —
University of Utah Salt Lake City Utah 84132 —
University of Virginia Health System Charlottesville Virginia 22903 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03470545, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03470545 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →